Cardiovascular disease is the leading cause of death in breast cancer survivor women. The magnitude of cardiotoxic effects depends not only on antineoplastic treatment, but also on individual susceptibility, which is determined by pre-existing cardiovascular disease and concurrent risk factors, as well as on prevention interventions, early identification and treatment of cardiotoxicity. The National Association of Cardiologists of Mexico, immersed in this reality, shares in this document an approach that explains the interaction of the two entities from the perspective of high-risk women and summarizes current detection and cardio-protection strategies.
CITATION STYLE
Parra-Machuca, M. G., Puente-Barragán, A. C., Ancona-Vadillo, A. E., Ruiz-Gastelum, E. D., Vásquez-Ortiz, Z. Y., Sierra-Galán, L. M., … Figueiras-Graillet, L. M. (2020). Approach to cardiovascular disease in women with breast cancer: a position statement of the National Association of Cardiologists of Mexico (ANCAM). Cardiovascular and Metabolic Science, 31(3), 76–103. https://doi.org/10.35366/95587
Mendeley helps you to discover research relevant for your work.